This ticker has not been starred yet LNTH Lantheus Holdings, Inc.
In Vitro & In Vivo Diagnostic Substances
Book value per $ invested $ 0.26
Leverage 50.83%
Market Cap $ 4.3B
PE 25.60
Dividend Yield 0.00%
Profit $ 168.9m
Margin 10.87%

Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.

Subscribe Now For Access - Only $1.99 Per Month